Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Denver, Colorado 80206


This study was designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.

Study summary:

This was a single-center, randomized, open-label, active-controlled, 2-period, 2-sequence, single dose-dose, crossover comparison of the ability of Albuterol BOI-HFA to produce bronchodilation relative to that produced by to albuterol MDI-HFA in at least 12 asthmatics with poor inhaler coordinating ability.


Inclusion Criteria: - Asthma diagnosed ≥6 months prior and stable for 4 weeks prior to screening - Poor inhaler coordination as assessed at screening - Reversible bronchoconstriction (≥ 12% increase in FEV1) Exclusion Criteria: - Albuterol allergy - Investigational drug within 30 days - Injected corticosteroid within 6 weeks - Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting beta-blockers, steroids other than those inhaled - Other criterial apply



Primary Contact:

Principal Investigator
Harold Nelson, MD
National Jewish Medical Center

Backup Contact:


Location Contact:

Denver, Colorado 80206
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.